Latest Articles

Publication Date
Applications open for Title X Family Planning Services Grants (US) - fundsforNGOs

Applications open for Title X Family Planning Services Grants (US) fundsforNGOs

Published: April 9, 2026, 7:38 a.m.
Endometrial organoids to model benign disorders affecting the endometrium.

The endometrium is a highly dynamic and complex tissue lining the uterus, playing a central role in reproductive health. Despite its importance, the pathogenesis of many benign endometrial disorders remains …

Published: March 31, 2026, midnight
With a Record 70 Spots this Year, Team EndoStrong Has Opened Applications for the 2026 NYC Marathon - Endometriosis Foundation of America

With a Record 70 Spots this Year, Team EndoStrong Has Opened Applications for the 2026 NYC Marathon Endometriosis Foundation of America

Published: March 30, 2026, 7:45 p.m.
Harnessing mangroves for epigenetic therapies.

Mangroves are valuable reservoirs of diverse phytochemicals with significant therapeutic potential. Beyond their ecological roles, these bioactive compounds can influence epigenetic mechanisms, heritable changes in gene expression without alterations in …

Published: March 30, 2026, midnight
EndoCyclic New Drug application approved by US FDA for endometriosis treatment - Pharmafile

EndoCyclic New Drug application approved by US FDA for endometriosis treatment Pharmafile

Published: March 25, 2026, 10:58 a.m.
FDA clears ENDO-205 Investigational New Drug application for endometriosis - Contemporary OB/GYN

FDA clears ENDO-205 Investigational New Drug application for endometriosis Contemporary OB/GYN

Published: March 23, 2026, 7:30 p.m.
EndoCyclic Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for ENDO-205, a First-in-Class Non-Hormonal Precision Peptide Therapeutic for Endometriosis - BioSpace

EndoCyclic Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for ENDO-205, a First-in-Class Non-Hormonal Precision Peptide Therapeutic for Endometriosis BioSpace

Published: March 23, 2026, 12:47 p.m.
EndoCyclic Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for ENDO-205, a First-in-Class Non-Hormonal Precision Peptide Therapeutic for Endometriosis - PR Newswire

EndoCyclic Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for ENDO-205, a First-in-Class Non-Hormonal Precision Peptide Therapeutic for Endometriosis PR Newswire

Published: March 23, 2026, 11:30 a.m.
Application of high-intensity focused ultrasound in gynaecological diseases.

High-intensity focused ultrasound (HIFU), a noninvasive treatment method, has attracted increasing attention in recent years for the management of gynaecological diseases. This review summarizes current literature on the application of …

Published: March 23, 2026, midnight
A heterogeneous graph neural network for candidate gene prediction in endometriosis.

Precision medicine applications depend on elucidating the underlying molecular mechanisms of disease. However, many disorders, such as endometriosis, remain poorly characterised genetically due to data scarcity, positive-unlabelled (PU) imbalance, and …

Published: March 23, 2026, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!